Rituximab as First-line Therapy for Severe Pemphigus: A Case Series and Review of Current Literature
Malaysian Journal of Dermatology
;
: 70-76, 2021.
Article
in English
| WPRIM
| ID: wpr-961862
ABSTRACT
Summary@#Pemphigus refers to a group of life-threatening, autoimmune blistering disease that presents as blisters and erosions involving the skin and mucosa. Systemic corticosteroids and rituximab have been recommended as mainstay therapy for pemphigus vulgaris and pemphigus foliaceus. Herein, we report three cases of pemphigus vulgaris and a case of pemphigus foliaceus treated with rituximab as first-line therapy.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Pemphigus
/
Rituximab
Language:
English
Journal:
Malaysian Journal of Dermatology
Year:
2021
Type:
Article
Similar
MEDLINE
...
LILACS
LIS